Katsu Takenaka Selected Research

Katsu Takenaka Research Topics

2	Hypertension (High Blood Pressure) 07/2008 - 01/2008
2	Orthostatic Intolerance 06/2007 - 03/2002
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 11/2020
1	Muscular Diseases (Myopathy) 11/2020
1	Hematologic Diseases (Blood Diseases) 10/2020
1	Coronary Occlusion 01/2019
1	Muscular Dystrophies (Muscular Dystrophy) 05/2016
1	Heart Failure 05/2015
1	Pulmonary Hypertension 05/2015
1	Bland White Garland Syndrome 12/2010
1	Left Ventricular Dysfunction 07/2008
1	Atherosclerosis 01/2008
1	Renal Insufficiency (Renal Failure) 05/2006
1	Cholesterol Embolism 05/2006
1	Ischemia 05/2006
1	Atherosclerotic Plaque (Atheroma) 05/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2005
1	Essential Hypertension 09/2004
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2004

1	DystrophinIBA 11/2020
1	IronIBA 01/2019
1	Cystatin CIBA 05/2016
1	Inulin FDA Link 05/2016
1	MonocrotalineIBA 05/2015
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 07/2008
1	imidaprilIBA 01/2008
1	Enalapril FDA LinkGeneric 01/2008
1	Losartan (Cozaar)FDA LinkGeneric 01/2008
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2008
1	Angiotensin Receptor AntagonistsIBA 01/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2006
1	CholesterolIBA 05/2006
1	SteroidsIBA 05/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2005
1	Amlodipine (Norvasc)FDA LinkGeneric 09/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2004
1	Dipyridamole (Persantine)FDA LinkGeneric 02/2004
1	Indicators and Reagents (Reagents)IBA 02/2004

1	Drug Therapy (Chemotherapy) 10/2020
1	Conservative Treatment 12/2010
1	Lower Body Negative Pressure 06/2007
1	Bed Rest (Bedrest) 03/2002